$199.00
BPC-157 is a synthetic pentadecapeptide supplied in a solid tablet format at 500 mcg per unit, with 30 tablets per container. It is produced for controlled laboratory workflows, with batch-specific Certificates of Analysis documenting peptide identity, content per unit, physical form, and relevant excipient information to support reproducibility and documentation control.
BPC-157 is evaluated in controlled in-vitro research systems investigating peptide-mediated signaling processes. These include studies focused on extracellular matrix regulation, cellular stress-response pathways, and related signal-transduction networks within defined laboratory assay platforms.
This peptide is characterized for use in analytical and cell-based research models examining concentration-response relationships, pathway activation profiles, and interaction networks at the cellular and molecular level. Applications are limited to laboratory assay designs and do not involve in-vivo contexts.
Each production lot is analytically verified at 99%+ purity using high-performance liquid chromatography, with identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytics. Manufacturing documentation, including Certificates of Analysis, raw-material provenance, and batch records, is maintained to support traceability and audit readiness.
